Plasma levels of di-no-propylacetate and clonazepam in epileptic patients. 1977

A Baruzzi, and B Bordo, and L Bossi, and D Castelli, and M Gerna, and G Tognoni, and P Zagnoni

Plasma levels of DPA and CNP and associated antiepileptic drugs were measured in groups of respectively 106 and 30 epileptic patients aged from 3 to 49 years. A poor correlation between daily oral dose and plasma levels of both drug was observed when the whole group of patients was considered. A better correlation was seen in a group of adult patients who received DPA and PB. Children below 10 years of age disposed both drugs faster than adults and the difference was significant (p less than 0.01) in groups receiving PB as associated drug. Patients medicated with PB and DPA or CNP showed lower plasma levels of both drugs; on the other hand DPA appeared to cause a decrease of PB clearance which was more marked in children. The clinical significance of the fluctuations of daily plasma levels of both drugs are discussed in relationship to the schedule of administration and plasma sampling. Observations on the therapeutic ranges and adverse effect of the drugs are reported.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002998 Clonazepam An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses. 2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-,Klonopin,Antelepsin,Rivotril,Ro 5-4023,Ro 54023
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001570 Benzodiazepinones
D014631 Valerates Derivatives of valeric acid, including its salts and esters. Pentanoate,Pentanoates,Valerate

Related Publications

A Baruzzi, and B Bordo, and L Bossi, and D Castelli, and M Gerna, and G Tognoni, and P Zagnoni
February 1975, European journal of clinical pharmacology,
A Baruzzi, and B Bordo, and L Bossi, and D Castelli, and M Gerna, and G Tognoni, and P Zagnoni
March 1980, Il Farmaco; edizione pratica,
A Baruzzi, and B Bordo, and L Bossi, and D Castelli, and M Gerna, and G Tognoni, and P Zagnoni
April 1991, Neuropeptides,
A Baruzzi, and B Bordo, and L Bossi, and D Castelli, and M Gerna, and G Tognoni, and P Zagnoni
October 1978, Journal of chromatography,
A Baruzzi, and B Bordo, and L Bossi, and D Castelli, and M Gerna, and G Tognoni, and P Zagnoni
January 1990, Brain & development,
A Baruzzi, and B Bordo, and L Bossi, and D Castelli, and M Gerna, and G Tognoni, and P Zagnoni
January 1988, Pediatrie,
A Baruzzi, and B Bordo, and L Bossi, and D Castelli, and M Gerna, and G Tognoni, and P Zagnoni
January 1976, Arzneimittel-Forschung,
A Baruzzi, and B Bordo, and L Bossi, and D Castelli, and M Gerna, and G Tognoni, and P Zagnoni
May 1983, Boletin medico del Hospital Infantil de Mexico,
A Baruzzi, and B Bordo, and L Bossi, and D Castelli, and M Gerna, and G Tognoni, and P Zagnoni
November 1998, Journal of chromatography. B, Biomedical sciences and applications,
A Baruzzi, and B Bordo, and L Bossi, and D Castelli, and M Gerna, and G Tognoni, and P Zagnoni
October 1977, British journal of clinical pharmacology,
Copied contents to your clipboard!